12 Publikationen
-
-
2020 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2940382Borbély AN, Thoreau F, Figueras Agustí E, et al. Synthesis and Biological Characterization of Monomeric and Tetrameric RGD-Cryptophycin Conjugates. Chemistry - A European Journal. 2020;26(12):2602-2605.PUB | PDF | DOI | WoS | PubMed | Europe PMC
-
-
2019 | Dissertation | PUB-ID: 2937966Borbély AN. Conjugates of Cryptophycin and RGD Peptides for Targeted Cancer Therapy. Bielefeld: Universität Bielefeld; 2019.PUB
-
-
-
2018 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2920953Figueras Agustí E, Borbély AN, Ismail M, Frese M, Sewald N. Novel unit B cryptophycin analogues as payloads for targeted therapy. Beilstein Journal of Organic Chemistry. 2018;14:1281-1286.PUB | DOI | WoS | PubMed | Europe PMC
-
2018 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2932984Cazzamalli S, Figueras Agustí E, Petho L, et al. In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas. ACS Omega. 2018;3(11):14726-14731.PUB | PDF | DOI | WoS | PubMed | Europe PMC
-
2018 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2944897Cazzamalli S, Figueras Agustí E, Pethő L, et al. Correction: In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma. ACS Omega. 2018;3(12):16743-16743.PUB | DOI | WoS | PubMed | Europe PMC
-
-
-